The Australian Dementia Network (ADNeT), Monash University, and Lilly Australia are proud to announce a new research collaboration aimed at deepening our understanding of the patient experience and societal impact of mild cognitive impairment and early Alzheimer’s disease. This landmark initiative represents the first collaboration of its kind in Australia between researchers, academia, and industry within the Alzheimer’s disease space. Read more below.

Vinay Prusty, Executive Director, Medical Neuroscience, Lilly, Professor Chris Rowe, Director, ADNeT, Professor Susannah Ahern, Clinical Registries, Monash University.